Literature DB >> 141484

Suppression of lymphoproliferation by high concentrations of normal human mononuclear leukocytes.

A H Laughter, J J Twomey.   

Abstract

Mononuclear leukocytes (MNL) include cells that suppress lymphoproliferation in unstimulated and antigen-stimulated cultures. Suppression is demonstrated by increasing the concentration of cells added to cultures and does not require preactivation of suppressor cells. Suprression of 3H-thymidine incorporation occurred if the high concentrations of MNL were added to cultures before the proliferative responses commenced. This suppressive effect of high cell concentration upon 3H-thymidine incorporation is removed by depleting MNL present in high numbers of cells that adhere to foreign surfaces or by preincubating these cells with cycloheximide, puromycin, or pactamycin. The suppressor cell, which only functions when present in a viable state, is radioresistant, adheres to foreign surfaces, remains active through 5 days in culture, and equates with the presence of a cell that is rich in cytoplasmic esterase. The suppressor cell may be of the monocyte series and did not appear to belong to either the T or the B lymphocyte series. This study provides additional evidence that normal immune reactivity in man is under regulatory control. The suppressor mechanism identified herein with normal human MNL is probably related to a similar type of suppression (but at a much lower cell concentration) that has been described with Hodgkin's disease and solid tumors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141484

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

Authors:  J J Twomey; A H Laughter; A D Steinberg
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

2.  Studies of rabbit testes infected with Treponema pallidum. III. Immunosuppressive activity of infiltrating mononuclear cells.

Authors:  V Wicher; K Wicher
Journal:  Br J Vener Dis       Date:  1984-02

3.  Studies on the suppression of a one-way mixed lymphocyte reaction by mitomycin-C treated responder cells.

Authors:  R M Victorino; H J Hodgson
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

4.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

5.  Monocyte-mediated regulation of cellular immunity in humans: loss of suppressor activity with ageing.

Authors:  M J Becker; I Drucker; R Farkas; Z Steiner; A Klajman
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

6.  Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

7.  Monocyte function in Hodgkin's disease.

Authors:  G Holm; M Björkholm; B Johansson; H Mellstedt; C Lindemalm
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

8.  Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans.

Authors:  I Pierri; S Rogna; D Pende; D Viglione; M Scudeletti; A Barabino; F Indiveri
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

9.  A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.

Authors:  T Suzuki; Y H Park; M Miyama-Inaba; T Masuda; H Saji; I Nagata; H Uchino
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

10.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.